VESELKA, Josef, Pavol TOMAŠOV, Jaroslav JANUŠKA, Jan KREJČÍ a Radka ADLOVÁ. Obstruction after alcohol septal ablation is associated with cardiovascular mortality events. Online. Heart. London: BMJ Publishing Group, 2016, roč. 102, č. 22, s. 1793-1796. ISSN 1355-6037. Dostupné z: https://dx.doi.org/10.1136/heartjnl-2016-309699. [citováno 2024-04-24]
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Obstruction after alcohol septal ablation is associated with cardiovascular mortality events
Autoři VESELKA, Josef (203 Česká republika), Pavol TOMAŠOV (203 Česká republika), Jaroslav JANUŠKA (203 Česká republika), Jan KREJČÍ (203 Česká republika, garant, domácí) a Radka ADLOVÁ (203 Česká republika)
Vydání Heart, London, BMJ Publishing Group, 2016, 1355-6037.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 6.059
Kód RIV RIV/00216224:14110/16:00091205
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1136/heartjnl-2016-309699
UT WoS 000387065200007
Klíčová slova anglicky TERM-FOLLOW-UP; LEFT-VENTRICULAR HYPERTROPHY; OUTFLOW TRACT OBSTRUCTION; SUDDEN CARDIAC DEATH; TASK-FORCE; CARDIOMYOPATHY; RISK; GUIDELINES; REDUCTION; DIAGNOSIS
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 26. 4. 2017 12:08.
Anotace
Background Left ventricular outflow tract obstruction (>= 30 mm Hg at rest; LVOTO) is considered a possible risk of long-term outcomes in patients with hypertrophic cardiomyopathy (HCM). However, the influence of LVOTO on the occurrence of cardiovascular mortality events in patients after alcohol septal ablation (ASA) for obstructive HCM remains unresolved. Methods We compared the outcomes of patients treated with ASA with residual LVOTO < 30 mm Hg with those with residual LVOTO >= 30 mm Hg at the first postdischarge check-up (1-6 months after the procedure). Results A total of 270 patients (60 +/- 12 years, median follow-up 5.1 years; 95% CI 4.5 to 5.9 years) treated with a single ASA were included; 208 (77%) and 62 (23%) patients had post-ASA LVOTO < 30 and >= 30 mm Hg at the first postdischarge clinical check-up, respectively (LVOTO 13 +/- 6 vs 50 +/- 27 mm Hg; p<0.01). Freedom from cardiovascular mortality events at 1, 5 and 10 years were 99% (95% CI 96% to 100%) vs 94% (95% CI 85% to 98%), 95% (95% CI 89% to 97%) vs 80% (95% CI 66% to 89%) and 82% (95% CI 69% to 89%) vs 72% (95% CI 55% to 84%) (log-rank test, p<0.01), respectively. In multivariable analysis adjusted for age at ASA, sex, baseline LVOTO and baseline septum thickness, the independent predictors of cardiovascular mortality events were early postdischarge LVOTO >= 30 mm Hg (HR 2.95, 95% CI 1.26 to 6.91; p=0.01) and baseline septum thickness (HR 1.07, 95% CI 1.01 to 1.13; p=0.02). Conclusions After ASA for obstructive HCM, LVOTO >= 30 mm Hg at the first postdischarge clinical check-up is associated with significantly higher occurrence of subsequent cardiovascular mortality events.
VytisknoutZobrazeno: 24. 4. 2024 12:07